Home > News & Conferences > News > AIT Toxicologist Outlines Compliance Testing Benefits in 'Pain Management' Q&A
Are you clear on the differences between urine and blood compliance testing and how a practice can benefit from each? Joshua Gunn, Ph.D. outlines the testing advantages unique to each matrix in a Q&A with “Pain Management” magazine, published in the February 2012 issue. One of several expert toxicologists at AIT Laboratories, Gunn covers a variety of topics in his interview, including his support of risk stratification as a means for guiding testing frequency and how healthcare practitioners can broach the subject of regular testing with their patients. He also discusses AIT Pathways®, AIT’s comprehensive suite of services for compliance testing and prescription drug testing to help HCPs customize their treatment plans and create better outcomes in their office.
“Pain Management” aims to provide pain professionals with the resources and information they need to provide the best patient care, on topics ranging from new technology to treatment advances to important regulatory decisions.
Read Gunn’s "Pain Management" Q&A online at PainLive.com.
AIT Laboratories, headquartered in Indianapolis, Ind., is a national healthcare company that specializes in compliance testing, forensic toxicology drug testing and clinical laboratory testing. The employee-owned company is recognized nationwide for superior customer service and quality in testing. AIT has been recognized by “Inc.” magazine as one of the top 5,000 fastest-growing, private companies in the nation for five consecutive years. In 2009, the Indiana Chamber of Commerce named AIT as the “Small Business of The Year.” Follow us on Twitter and like us on Facebook.